21 results
Thumbnail

D1.90 - Soft Tissue Loss Due to Allergic Reaction to Ahesive System during Orthodontic Treatment: A Case Report

Thumbnail

D1.91 - Characterization of Bet v1 Sensitized Patients in Madrid: A Real Life Study

Thumbnail

D1.93 - Isolated Generalized Pruritus Associated with SGLT2 Inhibitors: A Case Series with Negative Allergy Work-up

Thumbnail

D1.94 - Vancomycin- and Meropenem-Induced DRESS Confirmed by the Lymphocyte Transformation Test: A Synergistic Effect in Severe Drug Reactions

Thumbnail

D1.95 - Utility and safety of Patch Testing in anti-epileptic Induced DRESS: Diagnostic sensitivity and cross-reactivity profiling

Thumbnail

D1.96 - Assessment of sensitivity to Lipid Transfer Proteins in allergic patients in the Republic of Moldova

Thumbnail

D1.98 - Comparative Evaluation of Basal Serum Tryptase Determinants: Differential Impact of KIT D816V Allelic Load and HaT Gene Copy Number

Thumbnail

D1.99 - Allergic contact dermatitis caused by Trofoblastin

Thumbnail

D1.100 - Deciphering Multiple Drug Allergy syndrome: True Allergy or Pro-inflammatory Response ?

Thumbnail

D1.101 - Colchicine-induced hepatitis: a case of drug interaction involving rivaroxaban

Thumbnail

D1.102 - Furosemide-induced erythroderma: a diagnosis to consider

Thumbnail

D1.103 - Successful Class Switching of SGLT2 Inhibitors Following Empagliflozin-Induced Maculopapular Exanthema: A Case Report

Thumbnail

D1.97 - To FeNO or Not to FeNO: Is It a Practical Tool in Daily Management of Chronic Cough?

Thumbnail

D3.419 - Efficacy, safety, and remission outcomes of omalizumab in elderly patients with severe allergic asthma: a subgroup analysis by age of onset

Thumbnail

D3.420 - Real-world epidemiologic characteristics of patients treated with dupilumab for type 2 inflammatory indications: a single-center retrospective cohort study

Thumbnail

D3.422 - Dupilumab in children with multimorbid atopic phenotype: therapy efficacy, safety and biomarker changes

Thumbnail

D3.424 - Retrospective Analysis of Self-Administration of Biologic Treatments for Severe Asthma and Chronic Urticaria

Thumbnail

D3.426 - Predicting response to omalizumab in patients with chronic spontaneous urticaria: The first results of the global multicenter UCARE SCOPUS project

Thumbnail

D3.427 - Challenging the paradigm: Use of omalizumab in refractory angioedema in a 2-year-old child

Thumbnail

D3.428 - Substratification of Biologic Treatment Using Dupilumab in Eosinophilic COPD